@FiercePharma: Should Big Pharma spin off to goose shares? News | Follow @FiercePharma
> A jury in state Superior Court in Atlantic City said Fosamax, an osteoporosis medicine made by Merck, did not cause a Pennsylvania woman's jawbone to deteriorate. Article
> United Therapeutics is planning a major expansion of its research-and-manufacturing facility in North Carolina's Research Triangle Park that would allow it to triple its local work force. Report
> KV Pharmaceutical plans to sell nearly 10 million shares at $3.25 each to a group of institutional investors for a total of $32 million. News
> Pfizer has sold more than half of its former Brooklyn, N.Y., complex to a company planning to bring new light-manufacturing and commercial jobs to the long-shuttered site. Item
> Watson Pharmaceuticals' quarterly net income dropped due to legal and acquisition charges, but the generic drugmaker's profit excluding items was in line with analyst expectations. Article
> The Société générale de financement du Québec, a holding company for the provincial government, will proceeed with a $14.7 million equity reinvestment in Axcan Pharma to help fund its $587 million acquisition of Eurand Pharmaceuticals. Report
> Specialty pharmaceutical company Warner Chilcott forecast its 2011 profit range at $3.45 to $3.55 per share, in line with analyst estimates. Story
> Patients using aspirin for heart-attack prevention don't usually need proton pump inhibitors to reduce the risk of bleeding, a new study shows. News
Biotech News
@FierceBiotech: GSK plots new approach to working with academia. Story | Follow @FierceBiotech
@JohnCFierce: BIO: Overall success rates from Phase I to FDA approval is nearly 9%. Item | Follow @JohnCFierce
> Boston scores R&D coup with Merck KGaA's new hub. Item
> Philogen cancels IPO after Bayer pulls out of cancer deal. News
> Lilly to raise $750M to share R&D costs. Report
> Dealmakers: 2011 should see surge of new M&A pacts. Item
> Sinclair, IS Pharma in merger talks. News
Biotech Research News
> Scientists generate lab-dish human heart model. Article
> Obama pitches $1B boost to NIH funding. Story
> Mouse-human study IDs celiac disease triggers. Report
> Prostate cancer genome map spotlights DNA damage. News
> Charles River posts Q4 loss on preclinical writedown. Story
Manufacturing News
> Crucell wins back WHO with plant power fixes. Story
> Pfizer inherits Wyeth site clean-up. Item
> FDA zigs to inspect, zags to funds threat. Report
> CMO taps Capsugel for early-phase supply edge. News
> India considers drug-inspector job requirements. Article
> Pfizer taps DHL for Australia distribution. Story
And Finally... The non-profit organization that sets quality and safety standards for drugs approved by FDA is aiming to simplify, clarify and standardize the labels that are affixed to those drugs. Report